speb/financial-data huggingface dataset:
HALEOSLABS.NS income_statement (annual, 2023-03-31) — +Total Revenue: 3125480000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 596676000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 460611000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -521054000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 100000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -15691000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Amortization: 384000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 384000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 361000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 3023287.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Basic EPS: 37.92
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 9860000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 708712000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -485508000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 18533000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 30233000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 12778000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 36099000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -4535000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 12778000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -2808000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -168547000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 371255000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Change In Payable: -181162000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Change In Prepaid Assets: -12853000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -127423000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -121538000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 2918000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Common Stock: 30233000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 1686123000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 43343000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 2280029000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Current Assets: 1591165000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 5484000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Current Debt: 436948000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 442432000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 1335643000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 12814000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Depreciation: 107502000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 107886000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 107886000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 107502000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 3023287.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Diluted EPS: 37.92
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 114628000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 82000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — EBIT: 230169000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — EBITDA: 338055000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — End Cash Position: 12778000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 168884000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 248268000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -338558000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 12000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 32401000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 754000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 476302000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 2847214000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Gross Profit: 845451000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Interest Expense: 64240000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 64240000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Interest Income: 3953000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 3953000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -35257000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 1982000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Inventory: 862349000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 2672489000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -312916000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 361000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 327834000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 50145000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 13049000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 549418000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 562467000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 298071000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -114369000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 36231000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 2010535000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 196044000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Minority Interests: 854000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Net Debt: 973588000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Net Income: 114628000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 114628000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 113774000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 114628000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 114628000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 142413000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 113774000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Net Interest Income: -64708000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 110790000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 213465000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 183702000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -64708000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 2304000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Net PPE: 2326160000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -427992000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 29763000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 1685369000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 127614000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 41015000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 30466000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 314551000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Normalized Income: 98511307.20
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 146950000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Operating Income: 180470000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Operating Revenue: 3125480000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 3023287.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 403134000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 40000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 1610047000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 754000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 4780000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 36210000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -18000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -1000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 23564000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 67582000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Other Payable: 149402000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Other Properties: 34479000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 5419000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 23321000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Other Special Charges: -23504000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Payables: 746160000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 9437000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 12993000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 81622000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Pretax Income: 165929000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 5129000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -1172000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -485508000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 390706000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 2280029000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 107886000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 965000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 965000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -114369000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 8029000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 892079000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 111962000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 57516000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 22124000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 54525000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Share Issued: 3023287.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 29763000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Special Income Charges: 23504000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 1686123000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 1685369000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 7387307.20
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Tax Provision: 52155000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.31
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 137036000.00
HALEOSLABS.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -32599000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Total Assets: 3948906000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 2235541000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Total Debt: 1004899000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 1882167000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Total Expenses: 2945010000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 2066739000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 2357741000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 731096000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 4421000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 0.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 23504000.00
HALEOSLABS.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 23504000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Work In Process: 218595000.00
HALEOSLABS.NS balance_sheet (annual, 2023-03-31) — Working Capital: 255522000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — +Operating Expense: 744844000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — +Total Revenue: 2995605000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 591265000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 513505000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -660480000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 100000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -16174000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Amortization: 345000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 345000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 361000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 3023287.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Basic EPS: 30.08
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 12778000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 723832000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -208677000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 30125000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 30233000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 5695000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 5695000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -4535000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 5695000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 50245000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -397171000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 365152000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Change In Payable: -2179000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Change In Prepaid Assets: -2933000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -53377000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -40263000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -7084000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Common Stock: 30233000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 1768142000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 87344000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 2087926000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Current Assets: 1560818000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 6186000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Current Debt: 645662000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 651848000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 1453683000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 16595000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Depreciation: 149031000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 149376000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 149376000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 149031000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 3023287.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Diluted EPS: 30.08
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 90928000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 105000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — EBIT: 197996000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — EBITDA: 347372000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — End Cash Position: 5695000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -65636000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 252717000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 34378000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: 8000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 33870000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 495000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 529679000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 2980713000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Gross Profit: 907679000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Interest Expense: 99529000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 99529000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Interest Income: 2762000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 2762000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -62935000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 780000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Inventory: 812104000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 2745254000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -184503000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 361000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 166473000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 50145000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 23939000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 331450000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 355389000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -176231000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 47412000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 2077100000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 168224000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Minority Interests: 27650000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Net Debt: 971417000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Net Income: 90928000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 90928000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 63278000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 90928000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 90928000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 98467000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 63278000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Net Interest Income: -99869000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 23321000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -9758000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -176231000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -99869000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 1000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -1156000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Net PPE: 2320233000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -207448000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 166473000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 1767647000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 120437000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 47412000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 31380000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 347380000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Normalized Income: 90933141.05
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 243055000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Operating Income: 162835000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Operating Revenue: 2995605000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 3023287.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 211689000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 1000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 1737909000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 495000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 4671000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 61373000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 27334000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 17287000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 77882000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Other Payable: 98643000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Other Properties: 42292000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 6265000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 9230000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Other Special Charges: 8000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Payables: 698107000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 3613000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 16595000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 73780000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Pretax Income: 98467000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 483000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -208677000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 366568000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 2087926000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 149376000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 1083000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 1083000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -176231000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 9230000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 954098000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 23321000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 1229000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 24028000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 57898000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Share Issued: 3023287.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 166473000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Special Income Charges: -8000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 1768142000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 1767647000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -2858.95
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Tax Provision: 35189000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.36
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 140239000.00
HALEOSLABS.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -30000000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Total Assets: 3913287000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 2099592000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Total Debt: 1007237000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 1936366000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Total Expenses: 2832770000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 1976921000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 2352469000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 523238000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 3102000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 8094000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -8000.00
HALEOSLABS.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -8000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Work In Process: 188148000.00
HALEOSLABS.NS balance_sheet (annual, 2024-03-31) — Working Capital: 107135000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 561824000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 712164000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 31753000.00
HALEOSLABS.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 3022380.00
HALEOSLABS.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 15.46
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 27120000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 30233000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 2679000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 11923000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 30233000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 1877798000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 127781000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 1547002000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 6547000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 640417000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 646964000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 1439838000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 17443000.00
HALEOSLABS.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 3022380.00
HALEOSLABS.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 15.46
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 319000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 2300254000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 710913000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 2772736000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 31753000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 20573000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 254521000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 275094000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 52064000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 155385000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 892259000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 2300254000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 1877479000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 113854000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 3023287.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 112002000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 97005000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 1847565000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 34705000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 2172473000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 9244000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Payables: 584898000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 3023287.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 1877798000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 1877479000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 0.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 3914033000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 2132319000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 922058000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 2033183000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 1880850000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 2367031000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 441012000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 23074000.00
HALEOSLABS.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 107164000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 224320000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 846010000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 3022954.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 18.08
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 531714000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 37569000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 37569000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 3022954.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 18.08
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 54655000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — EBIT: 90550000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — EBITDA: 128119000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 314296000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 21379000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 21379000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 6124000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Net Income: 54655000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 54655000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 48531000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 54655000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 54655000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 48531000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -21379000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -21379000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 128119000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 54655000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Operating Income: 89976000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 846010000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 574000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 40737000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 69171000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 531714000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 37569000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 20640000.00
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.30
HALEOSLABS.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 756034000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — +Operating Expense: 980710000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 298420000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — +Total Revenue: 3447235000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 891124000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 532698000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 532698000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 687871000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 687871000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -801578000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -801578000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 100000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 100000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -66773000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -66773000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Amortization: 405000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 405000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 361000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 361000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 3023455.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 3024212.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Basic EPS: 66.51
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 9.83
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 5695000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 797089000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 797089000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -153486000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 23939000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 23939000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 30233000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 30233000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 5029000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5029000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5029000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5029000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -4535000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 5029000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 5029000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 138126000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -398957000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 471976000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Change In Payable: -56278000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Change In Prepaid Assets: -13482000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -224966000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -83581000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -666000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Common Stock: 30233000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 30233000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 1965603000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1965603000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 42733000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 42733000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 2166102000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 556471000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Current Assets: 1505737000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 1505737000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 6547000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 6547000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Current Debt: 657467000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 657467000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 664014000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 664014000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 1420675000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1420675000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 16205000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 16205000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Depreciation: 149967000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 149967000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 149967000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 37984000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 149967000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 37984000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 3023455.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 3024212.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Diluted EPS: 66.51
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 9.83
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 201090000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 29728000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 115000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 115000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — EBIT: 349024000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — EBIT: 59627000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — EBITDA: 498991000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — EBITDA: 97611000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — End Cash Position: 5029000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -191236000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 223143000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 223143000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 187063000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -310000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 32577000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 515000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 515000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 754644000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 754644000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 3162311000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3162311000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Gross Profit: 1281133000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 334653000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Interest Expense: 87125000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 20342000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 87125000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 20342000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Interest Income: 3076000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 3076000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -43082000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 628000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Inventory: 673979000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 673979000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 2805749000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2805749000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -149979000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 361000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 361000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 40567000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 50145000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 50145000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 17392000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 17392000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 182679000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 182679000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 200071000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 200071000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 3542000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -178000000.00